March 2, 2018 09:45 AM EST
Financing

Amid a bois­ter­ous fundrais­ing week, Bio­Med­Part­ners airs $107M biotech fund

Brittany Meiling

As the VC dol­lars con­tin­ue to dom­i­nate bio­phar­ma head­lines this week, Swiss VC group Bio­Med­Part­ners AG has an­nounced its own wind­fall: it’s raised an ad­di­tion­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times